MedTrace Logo

Postmarket Study of Tarvos Microguidewire in Neurovascular Interventional Surgery

NCT07500155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2026-04-02

No results posted yet for this study

Summary

This investigation is to evaluate the clinical effectiveness and safety of the Tarvos Microguidewire in the neurovascular interventional surgery. It is a retrospective multicenter medical device clinical study with real-world data.

Conditions

  • Intracranial Aneurysm
  • AVM - Cerebral Arteriovenous Malformation
  • AV Fistula
  • Acute Ischemic Stroke
  • Extracranial Atherosclerosis

Interventions

DEVICE

Tarvos Microguidewire

This product is indicated for use in neurovascular interventions to assist in the delivery of diagnostic or therapeutic devices to the target lesion site.

Sponsors & Collaborators

  • Keuro MedTech

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-29
Primary Completion
2026-03-15
Completion
2026-03-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07500155 on ClinicalTrials.gov